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Problems in Renal Homotransplantation 
Thomas E. Starzl, MD, Thomas L. Marchioro, MD, Robert S .  Brittain, MD, 
Joseph H .  Holmes, MD, and William R.  Waddell, MD, Denver 
S INCE NOVEMBER, 1962, 12 renal homograft- ing procedures, exclusive of a previously re- 
ported isograft ' between identical twins, have been 
performed at the University of Colorado Medical 
Center. During this period numerous observations 
have been made which bear on various aspects of 
the complex care of these patients, including ( a )  
technical refinements in the procurement, preserva- 
tion, and implantation of the kidneys, ( b )  selection 
of donor sources, and ( c )  prevention, recognition, 
and reversal of the rejection process. An evaluation 
of the early results in these cases provides hope that 
renal homografts may be performed with a higher 
success rate than previously thought possible. 
Materials and Methods 
Case Material.-The cases have been divided into 
two categories (Table). The first group of ten pa- 
tients received homografts from living donors. The 
second group consisted of two patients for whom 
the renal homografts were obtained from recently 
deceased cadavers. The patients were all males 
ranging from 12 to 50 years of age. Renal failure 
was due to end-stage chronic glomerulonephritis in 
ten patients. One patient was referred after unin- 
tentional surgical removal of his only kidney. The 
oldest patient had polycystic disease. Uremia had 
been present for many months or years except in the 
patient with inadvertent nephrectomy. In all except 
Patient No. 9 multiple preoperative hemodialyses 
were required as often as 24 times (case 1 ) .  
Donor Selection.-Familial relationships of don- 
ors to the 12 patients are indicated in the Table. 
There was one mother-to-son and five sibling dona- 
tions, including two from fraternal twins. In the 
other six patients there was no genetic relationship. 
Three kidneys were contributed by females to males. 
With living donors, evaluation of renal function 
was not exhaustive in the absence of a history of 
renal disease. Blood urea nitrogen (BUN) levels 
and creatinine clearance were determined. An intra- 
venous pyelogram was obtained. Aortography was 
carried out in eight of the ten living donors as rec- 
ommended by Goodwin "nd Hume." The informa- 
tion obtained was useful in selecting the donor 
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kidney. In two patients a double renal arterial sup- 
ply was found on one side, prompting use of the 
contralateral kidney. In a third patient, two renal 
arteries were found to the kidney which was even- 
tually used and three to the contralateral kidney. In 
a fourth patient, double renal arteries were seen on 
both sides, with a large and diminutive pair on the 
left side and two medium-sized arteries on the 
right. The right kidney was selected for technical 
reasons. When convenient, donors were selected of 
the same major blood type as the recipient. How- 
ever, in six of the 12 cases, there were major blood 
group incompatibilities ( Table). 
In two cases living donors were obtained from 
rather unusual sources. A 42-year-old male volun- 
teered a kidney to a 50-year-old man with polycystic 
renal disease as the result of a newspaper appeal 
by the patient's wife. A second kidney was donated 
by a convict from the Colorado State Prison. His 
recovery from nephrectomy was rapid. Twelve days 
after the operations-he disappeared from the ward 
and has not been seen since. 
The cadaveric kidneys were both obtained from 
patients dying of central nervous system (CNS) 
disease. The first was a 32-year-old man who was 
thought to have a brain tumor. Subsequent complete 
autopsy revealed the presence of acute bacterial 
endocarditis with CNS sepsis. The contralateral kid- 
ney, studied at autopsy, had no evidence of involve- 
ment with septic emboli. The second cadaveric 
kidney was obtained from a 47-year-old patient who 
died of subarachnoid hemorrhage. Both patients 
were hypotensive for several hours before death. 
Preservation of Renal Tissue During Homogruft- 
ing.-The kidneys were protected from the effects of 
ischemia in three ways, all involving cooling. The 
five living donors whose major blood groups were 
the same as those of the recipient patients received 
total body coding to 30 to 32 C (86 to 89.6 F). 
In addition, they were given 2 mg per kilogram of 
body weight of heparin sodium intravenously ten 
minutes before the renal artery was occluded. Im- 
mediately after removal of the kidney, a neutral- 
izing intravenous dose of hexadimethrine bromide 
was administered. The five living donors who had 
major blood groups different from those of the re- 
cipients did.not receive total body hypothermia or 
heparin sodium. The kidney was removed and im- 
mediately perfused with several hundred milliliters 
of cooled lactated Ringer's solution at 5 to 15 C (41 
Vol 187, No 10 RENAL HOMOTRANSPLANTATION-STARZL ET AL 735 
to 59 F) to which 1 gm of procaine chloride and 50 
mg of heparin sodium per liter had been added." 
The two cadaveric kidneys were obtained by a re- 
cently described method of extracorporeal total body 
hypothermic perfusion which was instituted within 
a few minutes after death. As soon as the cadaver 
perfusion had been started, the abdomen was opened 
and dissection of the prospective homograft done. 
Technical Considerations.-Donor nephredomy 
was performed through an extraperitoneal lateral 
incision in living donors and throu& a midline 
abdominal incision in cadavers. Great care was taken 
to avoid inadvertent acclusion of the renal artery or 
vein during dissection. Special precautions were 
taken to preserve the blood supply to the renal pel- 
vis and ureter.' An attempt was made to remove all 
adventitia at the point where the renal artery and 
vein were transected in order to facilitate subse- 
quent anastomoses. 
The recipient bed was prepared by an extraperi- 
toneal approach through an oblique lower abdom- 
inal incision on the left in seven patients and on the 
right in five. The technique of Murray and Harri- 
son " was used with placement of the left donor kid- 
ney in the right iliac fossa (Fig 1) and the right 
donor kidney in the left iliac fossa, thereby reversing 
the anteroposterior relationships of the renal ped- 
icle. The venous, arterial, and ureteral anastomoses 
were ~erformed in that order. In five of the 12 Da- 
A 
tients the presence of venous valves in the external 
iliac vein were noted and the end-to-side anasto- 
moses placed either above or below these struc- 
tures. End-to-end arterial anastomoses using 6-0 silk 
were performed to the hypogastric artery in the 
nine patients with single renal arteries (Fig 1). In 
three patients there were two renal arteries and the 
anastomoses were performed to suitable branches 
of the hypogastric artery. The necessity for double 
arterial anastomoses materially increased the ische- 
mia time (Table). In almost all patients there was a 
disparity in size between the vessels used for arterial 
anastomosis. Under these circumstances, the smaller 
of the arteries was dilated with the tip of a hemo- 
Fig. 2.-Left, Record of patient 1 shows vigorous rejection 
attempt two weeks after operation despite profound leuko- 
penia induced with 4 0 0  r total body irradiation. Azathio- 
prine dose given in total milligrams per day because 
patient gained weight rapidly postoperatively (22 to 4 1  




Fig 1.-Position of renal homograft in recipient site. Peri- 
toneal cavity is not entered. Note tunnel and nipple tech- 
nique used for ureteral implantation. 
stat. Ureterocystostomy was performed with a sub- 
mucosal tunnel and nipple technique (Fig I ) .  
Urethral drainage was used for 24 to 72 hours post- 
operatively. 
During revascularization of the kidney, 250 mg/kg 
of mannitol were given intravenously. If urine flow 
subsequently was demonstrated from the ureteral 
tip, an additional 30 to 50 gm of mannitol was ad- 
ministered in 20% solution at 4 to 6 ml per minute 
and ipsilateral nephrectomy was performed through 
the same incision if this had not been done previously 
( Table). In two patients the contralateral kidney 
was also removed on the day of transplantation. In 
rectomy and splenectomy. r=dose in roentgens. Acti-C= 
intravenous Actinomycin C. CCr=creatinine clearance.) 
Right, record of patient 2 shows rejection bwinning after 
two weeks. Left nephrectomy and splenectomy done same 
day as transplantation. Right kidney has not been re- 








Cases of Renal Homotransplantation* 
Donor to  
Patient Recipient Date of Date of Left Right Date of Age (Yr) and Duration Renal 
No. and Blood Thymec- Splenec- Nephrec- Nephrec- Trans- Relation of Rejection Function 
Age (Yr) Types tomy tomy tomy tomy plant of Donor Ischemia Attempt Outcome 6-1-63 
Homograft with Living Donor 
1 (12) B+-B+ 10-23-62 11-4-62 11-4-62 11-4-62 11-24-62 35 (mother) 34 min 14 days Alive Good 
2 (38) B+-A+ 1-17-63 1-31-63 1-31-63 Not done 1-31-63 32 (sister) 28 min 27 days Alive Good 
3 (21) A+-A+ 1-24-63 2-2-63 2-2-63 2-9-63 2-9-63 21 (fraternal 24 min 0 Alive Good 
twln) 
4 (34) A+-AB+ 2-12-63 2-12-63 2-12-63 2-12-63 2-25-63 30 (wife) 36 min 17 days Alive Good 
-- 
42 days 
5 (50) A+-At- 2-26-63 2-26-63 Not done Not done 3-26-63 42 (unre- 71 m i n t  Hard to Died 10 days ........ 
- lated) (2 arteries) assess seps~s 
6 (23) O+-O+ 3-22-63 3-22-63 4-17-63 4-24-63 4-17-63 22 (brother) 35 min 21 days Alive Good 
7 (25) O+-A+ 0 5-3-63 5-3-63 Not done 5-3-63 32 (wife) 41 min 14 days Alive BUN level 38 (2 arteries) mg% 
8 (29) 0+-O+ 0 5-8-63 Congen- 4-25-63 5-8-63 20 (brother) 61 min 4 days Alive Good 
itally Elsewhere (2 arteries) 
Absent 
9 (30) O+-A+ 2-14-63 2-14-63 5-10-63 5-10-63 5-10-63 30 (fraternal 28 min 5 days Alive Good 
twin) 
10 (47) O+-0- 0 5-15-63 5-15-63 5-15-63 5-15-63 32 (unre- 38 min 4 days Alive Good 
lated) 
Homograft with Cadaver Donor 
11 (21) A+-O+ 0 0 Not done Not done 3-19-63 32 (unre- 106 min Hard to Died 24 days ........ 
lated) from assess sepsls 
death 
12 (29) A+-A+ 3-27-63 3-27-63 4-18-63 4-18-63 4-19-63 47 (unre- 124 min AnuricS Died hemor- ........ 
lated) from rhage 40 
death days post- 
operatively 
'All donors and recipients were males unless otherwise indicated. 
?Cardiac arrest durina transolantation. 
$Homograft removed-12 days; ruptured. 
four patients concomitant splenectomy was per- 
formed through a separation incision (Table). 
Methods to Prevent Rejection.-In principle, all 
~atients exceDt the ~a t i en t  in case 1 received similar 
antirejection *thera&. The first patient was treated 
with 300 roentgens ( r )  of total body irradiation (at 
depth) preoperatively. Fifty r were given 17, 14, 11, 
and 5 days before transplantation, culminating in a 
final dose of 100 r on the day before operation. Four 
and six days after transplantation, additional doses 
of 50 r were given (Fig 2) ,  shielding the renal 
transplant on the second of these occasions. The x-ray 
doses were given with a 250 kv unit at 30 ma, half- 
value layer 2.5 mm copper, with a Thoraeus filter at 
a distance of 207 crn to the near surface in lateral 
position. Maximum tissue thickness was 19 cm and 
the dosage rate at the midline was 3.48 r per min- 
ute. Despite the resultant suppression of white 
blood cell (WBC) count to less than 500/cu mm, 
vigorous rejection began after two weeks (Fig 2). 
Therapy was changed to azathioprine ( Imuran ) , 
actinomycin C, and prednisone with apparent re- 
versal of the rejection. 
Therapy for the last 11 patients consisted of a 
combination of azathioprine, adinomycin C, and 
prednisone. The basic azathioprine therapy was 
started 1 to 19 days before transplantation in a dos- 
age of 3 to 8 mg/kg per day. On the day of surgery 
and for two or three days thereafter the dosage was 
increased to 6 to 15 mg/kg per day. In patients who 
were unable to take the drug orally it was adminis- 
tered intravenouslv in isotonic sodium chloride so- 
lution to which one molecular equivalent of sodium 
hydroxide and 2 mg/ml of azathioprine were added. 
Thereafter the dosage was reduced to 3 to 6 mg/kg 
per day. WBC counts were obtained daily and the 
dosage of azathhprine was regulated accordingly in 
the attempt to avoid the production of leukopenia. 
In three patients, prednisone in a dosage of 30 to 
100 mg per day was started before surgery and 
continuued after. In the other nine, steroids were 
withheld until the threat of rejection appeared. 
Actinomycin C was added to the regimen as dis- 
cussed in the next section. 
In addition, portions of the lymphoid system were 
excised. Eight patients had both splenectomy and 
thymectomy performed at varying intervals before 
or at the time of transplantation (Table). Three of 
the 12 patients had splenectomy alone. The one pa- 
tient who received no adjuvant surgical procedure 
(case 11) received a renal homograft during a bout 
of uncontrollable gastrointestinal bleeding at a time 
when his condition was too precarious to allow con- 
sideration of concomitant splenectomy. 
Reversal of Rejection.-A most important factor 
of success in these cases was the ability to halt and 
reverse the attempted rejection which occurred in 
11 of the 12 patients, from 4 to 27 days after trans- 
plantation. The earliest and most subtle evidence 
that rejection was at hand was persistent elevation 
of the blood pressure and fluid retention. Shortly 
thereafter there was increased excretion of protein 
in the urine, elevations in BUN and creatinine lev- 
els, depression of creatinine clearance, and oliguria 
or anuria. These events were accompanied by fever, 
often to 41 C (105.8 F ) .  
As soon as the diagnosis of rejection was made, 
oral prednisone was increased to 150 to 400 mg per 
day in those patients already receiving smaller 
quantities or was immediately started at this dosage 
level in the others. The high steroid doses were con- 
tinued for as long as 14 days and then slowly re- 
duced to maintenance therapy of 10 to 20 mg per 
day. A first course of 400-gamma actinomycin C was 
given intravenously and repeated every five to seven 
days thereafter until renal function returned to nor- 
mal. During these emergency measures, azathioprine 
was continued, ideally, without any reduction in 
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dose. The most serious problems of management 
occurred in tho'se patients in whom the advent of 
rejection coincided with the development of leuko- 
~en ia .  When the dose of azathio~rine was lowered 
A A 
or stopped under these circumstances to avoid fatal 
agranulocytosis, rejection proceeded with great 
vigor (Fig 2) despite the presence of a depressed 
WBC count. Salt and fluid restriction were insti- 
tuted and antihypertensive drug therapy started. In 
a few days restoration of adequate renal function 
began in nine of the ten patients who had received 
kidneys from living donors (Fig 2). There has been 
only one subsequent mild rejection attempt (case 
4 )  which was easily controlled. 
Results 
Deaths.-There were three deaths in the series of 
12 patients. In the group of ten patients receiving 
kidneys from living donors there was one fatality. 
A 50-year-old man with polycystic kidney disease 
received a renal transplant from an unrelated volun- 
teer donor on March 26, 1963. Splenectomy and 
thyrnectomy had been performed one month previ- 
ouslv. Develo~ment of a mediastinal hematoma had 
L 
complicated his convalescence, causing an unrecog- 
nized hemorrhagic pericarditis. During the trans- 
plantation operation cardiac arrest developed just 
before the renal arterial anastomosis was completed. 
Open cardiac massage resulted in restitution of cir- 
culation. Urine flow from the homograft was de- 
layed for 12 hours, but was 2,000 to 4,000 ml per 
day thereafter. The patient received excessive doses 
of azathioprine before and the first few days after 
transplantation with a consequent marked leuko- 
penia first observed on the seventh postoperative 
day. He died of mediastinitis and generalized sepsis 
on the tenth postoperative day. The histologic find- 
ings of rejection were not present in the renal 
homograft, although there was evidence of tubular 
necrosis which was probably related to the pro- 
longed ischemia at the time of transplantation. 
The other two deaths occurred in patients who 
received cadaveric kidnevs. The first of these was 
a 21-year-old man in whom urine flow was delayed 
for eight hours after transplantation. Unfortunately, 
the transplantation wound was made a short dis- 
tance from an infected dialysis site in the right 
groin. The transplant wound first drained copious 
amounts of lymph. After ten days it became grossly 
infected and had to be widely opened for drainage. 
Ultimately the patient developed a Pseudomom 
septicemia and died of generalized sepsis. The bac- 
terial complication was rendered uncontrollable by 
the development of leukopenia with a WBC count 
of 300/cu mm. Terminally, function of the renal 
homograft deteriorated. At autopsy there was no 
evidence of rejection in the homograft, although 
there was extensive renal parenchymal destruction, 
secondary to arteriolitis, which was histologically 
comparable to that seen in malignant hypertension. 
The other patient receiving a cadaveric kidney 
AZATHIO- 15 
PRlNE .: 
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Fig 3.-Patient 3 only one in whom rejection crisis was not 
encountered. (Dxdialysis. TH=thymectomy. LNS= left 
nephrectomy and splenectomy.) Right splenectomy was per- 
formed at  time of transplantation. 
also died. He was a 29-year-old man who had pre- 
viously undergone splenectomy and thymectomy. 
The renal graft, which was revascularized 124 min- 
utes after the death of the donor, never functioned 
satisfactorily. The maximum urine flow was 5 cc 
per hour. Eleven days after transplantation he was 
reported to have fallen out of bed and 24 hours 
later it was necessary to remove the homograft 
which had ruptured. Following this, he developed 
a hemolytic staphylococcal septicemia. Two weeks 
after removal of the homograft, at a time when he 
was being considered for a second homotransplan- 
tation, a mediastinal abscess developed from the 
site of the previous thymectomy. He was main- 
tained on hemodialyses during efforts to heal his 
wounds. On May 28, 40 days after his original 
homografting procedure, the connections of the 
chronic dialysis shunt became dislodged as he 
slept and he hemorrhaged to death from !]is in- 
dwelling arterial catheter. The renal 11oc.~)?rait, 
which was removed 12 days after its implan:ation, 
was grossly swollen and showed extensil e in:ilcra- 
tion with mononuclear cells. The picture was histo- 
logically compatible with rejection. 
Complications.-The nonfatal complicationu of 
hypertension, fluid retention, and fever which ac- 
company a threatened rejection have already been 
mentioned. Perhaps the most dramatic non atal 
complication occurred in case 4. The patient had a 
massive pulmonary embolus five weeks acd two 
days after transplantation which was successfully 
removed by pulmonary embolectomy. Peripheral 
thrombophlebitis without embolism occurred in 
cases 2 and 11. Many of the patients had numerous 
superficial wound infections prior to renal trans- 
plantation resulting from multiple hemodialysis. 
Healing of these indolent wounds usually occurred 
rapidly after the homografts had been placed. 
Three of the patients (cases 2, 3, and 8) developed 
psychiatric disorders in the postoperative period, 
long-term psychiatric care being required in one. 
One patient developed a leak at the ureterocystos- 
tomy (case 7).  He was re-explored six days after 
the original operation and reimplantation was satis- 
factorily carried out. 
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Postoperative Renal Function.-The retarded or 
absent early renal function in the three patients 
who died has already been mentioned. The nine 
surviving patients all had an immediate dramatic 
diuresis followed by a period of normal renal func- 
tion lasting from 4 to 27 days and which was inter- 
rupted by an attempted rejection in all except 
case 3 (Fig 3 ) .  After reversal of the rejection there 
was rapid return of renal function to essentially 
normal levels. This has been most thoroughly 
studied in the first five patients who survived. 
These patients have been followed for 1% to 6% 
months and all have normal BUN levels, creatinine 
level, and creatinine clearance. The graphic record 
of three of these patients is illustrated in Fig 2 and 
3. The last four patients have been operated on in 
the last four weeks and all have just emerged from 
rejection crises. Three of these four patients have 
experienced return of normal renal function, while 
the fourth has been indolent in his response to the 
antirejection therapy and still has a BUN level of 
38 mg%. 
Comment 
The use of renal hoinografts in humans has not 
usually been successf~~l. Recently, Goodwin and 
Martin ~ c c u m u l a t e d  published and unpublished 
data on renal homografts from various parts of the 
world. Of almost 200 cases available for analvsis in 
this collected series, only six patients are known to 
have lived as long as one year. Most commonly, 
death occurred within a few weeks or months after 
surgery, since less than 10% of the patients whose 
cases have been recorded lived for as long as three 
- 
months. 
Most of the following remarks will serve to focus 
attention on some of the preoperative and post- 
operative details which may have contributed to 
the somewhat higher early success rate in the pres- 
ent series. In the patients receiving kidneys from 
living donors, nine of ten are well from one to six 
months after surgery and all of these have adequate 
renal function as of June 1, 1963. The problems to 
be discussed can be broadly classified into two 
categories: technical and biological. 
There has been a tendency to believe that the 
technical factors are of secondary importance. Those 
holding this point of view allude to the almost uni- 
form success of renal transplantation between iden- 
tical twins, despite great differences in the trauma 
inflicted upon the donated kidney in terms of 
ischemia and organ temperature during its devas- 
cularization. An alternative view could be sup- 
ported easily, based upon the contention that the 
margin of safety in identical twins (isografts) is 
incomparably greater than with true homografts. 
Even though severe, but reversible, renal injury 
occurs, steady improvement may be expected, since 
a secondary parenchymal insult does not occur 
when isografts are used. In contrast, the recovery 
of homograft function is almost inevitably inter- 
rupted by a rejection phase. The ability of the graft 
to remain viable is almost surely related, at least to 
some extent, to the quality of the tissue at the time 
of the rejection crisis. It is perhaps significant that 
the three failures in the present series occurred in 
the patients who received the most severely trau- 
matized homografts. Greatest trauma occurred in 
two from cadavers and in a third after an excessive 
period of ischemia which resulted from the neces- 
sity of interrupting the vascular anastomoses to 
treat a cardiac arrest. Although urine flow was 
observed in two of the three patients, renal func- 
tion was greatly retarded. 
Aside from efforts to minimize the period of 
ischemia during transfer of the graft, other measures 
were taken to protect the donated tissue. Care was 
exercised in mobilization and dissection of the kid- 
ney to avoid inadvertent occlusion of the vessels. 
Cooling was provided by either total body hypo- 
thermia or cold perfusion. The donated organ was 
also heparinized, either by giving heparin sodium 
systemically to the donor ' or by direct perfusion 
into the renal artery with cold so1utio.n after com- 
pletion of nephrectomy." Finally, the osmotic diure- 
sis, which would be anticipated as the result of a 
high degree of urea concentration, was reinforced 
with mannitol intravenously administered to the 
recipient patient during and after the vascular 
anastomoses. Optimally prepared kidneys invariably 
exhibited a massive diuresis, starting within 5 to 20 
minutes after reconstitution of renal blood flow. 
BUN level was usually restored to normal within 
24 to 72 hours. Normal renal function then con- 
tinued until the beginning of rejection. 
The kidney having been transplanted with the 
minimum of operative injury, continued function 
of the homograft is dependent upon the adequacy 
of the antirejection therapy. The most important 
single agent is azathioprine,' a purine analogue. 
The drug is used essentially as reported in the 
pioneer work of Murray and Calne and their asso- 
ciates,"" with the exception of a few possibly im- 
portant details. Studies in our laboratory have indi- 
cated that homograft survival is greatly increased 
in dogs treated with azathioprine for two or three 
weeks before, as well as after, transplantation in 
comparison to a comparable group pretreated for 
one or two days. Consequently, eight of the 12 
patients received the drug for 4 to 19 days before 
operation. 
Originally, it was thought that it would be de- 
sirable to gradually suppress the WBC count with 
azathioprine during the early postoperative period 
so that the appearance of rejection would coincide 
with the development of leukopenia. This proved to 
be the most costly error in the management of the 
present series of cases. The effectiveness of therapy 
is not directly related to the degree of bone marrow 
depression and the necessity for withdrawal of the 
drug because of agranulocytosis at a time when it 
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is most needed does nothing but decrease the 
chances for success. Variants of this error were 
committed in the three patients who died. Sepsis 
eventually developed in all, as well as deterioration 
of renal function. 
In spite of the value of azathioprine, it is doubt- 
ful that survival of the homograft would have been 
possible in most of the cases without the use of 
secondary drug therapy. Particularly in those pa- 
tients with violent rejection crises, the clinical pic- 
ture of acute renal failure, fever, and tenderness 
in the transplant area was so alarming as to leave 
little hope for recovery. The additional administra- 
tion of high doses of prednisone and actinomycin C 
regularly resulted in the reversal of these events. 
Unfortunately, the combined use of actinomycin C 
and prednisone precludes an accurate clinical eval- 
uation of the effect of either agent alone. However, 
GoodwinQ has described a case in which the only 
additional drug used was prednisone in a child 
undergoing rejection while under treatment with 
mechlorethamine hydrochloride (nitrogen mustard) 
and cyclophosphamide. In our laboratory it has been 
possible to test the effect of prednisone on nine dogs 
undergoing rejection while on azathioprine ther- 
apy, in eight of which evidence of reversal of rejec- 
tion occurred. Also in dogs, Murray8 has reported 
the reversal of rejection using actinomycin C in 
combination with continuing azathioprine therapy. 
The single most important factor contributing to 
early success is proper management of the rejection 
crisis. If the patient has been treated with a rela- 
tively stable dose of azathioprine, it is possible to 
continue this therapy with the addition of the sec- 
ondary drugs mentioned above. At this point, the 
greatest virtue is patience. While it is tempting to 
suspect mechanical factors as a cause for the clini- 
cal situation, it is now our opinion that the essential 
anatomic integrity of the transplant must be taken 
on faith at the time of the almost inevitable 
attempted graft repudiation. Instrumentation is 
scrupulously avoided. Furthermore, the temptation 
is great to make impetuous changes in the azathio- 
prine therapy in an effort to suppress the WBC 
count. This has seemed to be undesirable. Although 
azathioprine dosages can frequently be increased, 
the dose should be selected with a view to avoid- 
ing profound bone marrow depression. With this 
general approach, the seriously depressed renal 
function has consistently returned, often after many 
agonizing days of waiting. 
From the above remarks it is evident that the 
critical alterations in the immunologic mechanism 
were brought about by pharmacological means. 
Deserving of additional comment is the role of 
thymectomy and splenectomy in mitigating the 
vigor of the rejection response. If these additional 
operative procedures have any value, it is certainly 
adjuvant in scope, since neither splenectomy nm 
thymectomy can potentiate homograft survival in 
the adult experimental animal when used alone. In 
our laboratory, efforts to demonstrate an increased 
survival in dogs treated with azathioprine by the 
addition of splenectomy and thymectomy have not 
produced statistically convincing evidence of the 
value of extirpation of these lymphoid masses. Our 
use of these procedures should, therefore, be inter- 
prated as a clinical trial rather than a recommenda- 
tion for their use. The ultimate role of thymectomy 
and splenectomy will require long-term follow-up 
and careful evaluation of late results. This admoni- 
tion is particularly germane, since thymectomy has 
proved to be a relatively dangerous operation in 
the presence of uremia. Two patients have devel- 
oped mediastinal hematomas after this procedure 
which led to death before transplantation could be 
carried out. Mediastinal abscesses complicated the 
course of two additional patients. 
Despite the necessity for caution in recommend- 
ing adjuvant splenectomy and thymectomy, consid- 
erable experimental information is available which 
suggests the need for evaluation of these measures 
under highly controlled circumstances. Both old 
and more recent experimental studies have demon- 
strated that the antibody response to many anti- 
gens is reduced after ~plenectomy.'~~ " Wissler and 
his colleagues l 2  believe that the spleen is the most 
active portion of the lymphoid system in response 
to antigens given intravenously. They have sug- 
gested that sensitized lymphoid tissue within the 
spleen can ultimately leave this organ and repopu- 
late other lvm~hoid centers with the establishment , L 
of specific clones in widesmead locations. 
Less evidence can be cited that the thvmus occu- 
pies an important role in maintaining immunologic 
reactivity in the adult state, since the thymus can- 
not be demonstrated to contribute to the antibody 
response to antigens in grown experimental ani- 
mals.'Vn adult mice, Miller l4 has shown that 
thymectomy, combined with total body irradiation, 
can result in homograft tolerance of a high deqee, 
far exceeding that resulting from irradiation alone. 
This finding suggests that the thymus may, in adult 
life, resume the preceptor function which it is 
thought to provide for immunologic development 
in the fetal and newborn state,15 providing there is 
first a temporary suppression of the mature lympho- 
~oietic svstem.14 Miller's observations. however. re- 
Lain to'be confirmed both in mice and in h iher  
species. The thymus glands removed in the present 
series of patients all showed atrophy to such a 
degree that the resumption of an important func- 
tional role by this fibrotic, fat-infiltrated tissue is 
difficult to imagine. The validity of application of 
Miller's concept to human renal homotransplanta- 
tion will have to wait long-term follow-up of cases 
such as these. 
Summary 
Twelve patients with terminal uremia were 
treated with renal homotransplantation. The homo- 
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grafts were obtained from blood relatives in six 
cases, unrelated living donors in four, and from 
recently deceased cadavers in the other two cases. 
The presence of major blood group incompatibili- 
ties or differences of sex in the donor and recipient 
patients did not adversely influence the outcome. 
Particular attention was focused on two aspects 
of the transplantation problem. First, an effort was 
made to improve the quality of the homograft 
tissue by reducing its period of ischemia during 
transfer and by reducing its metabolic require- 
ments during this period by one of three cooling 
techniques. Second, it was attempted to improve 
the methods used for prevention and reversal of the 
rejection crisis which interrupted the recovery of 
every patient except one. The greatest progress 
appeared to be in the proper manipulation of drugs 
so that they were maximally effective at the time of 
greatest need-during the height of the attempted 
rejection. In addition, a clinical study was initiated 
in these patients to determine if surgical excision of 
the thymus and spleen is of value in mitigating the 
vigor of the immunologic response to the foreign 
tissue. The worth, if any, of these adjuvant surgical 
measures will have to wait long-term follow-up of 
the present series of cases. 
Nine of the ten patients who received renal 
homografts from living donors have good renal 
function from two weeks to 6I/z months postoper- 
atively. The tenth patient, as well as both recipients 
of cadaveric kidneys, succumbed with a combined 
picture of inadequate renal function and sepsis. 
Addendum 
On Dec 15, 1963, the patients in cases 1, 2, 3, 6, 
and 10 are alive with normal renal function 7 to 13 
months after surgery. All five of the patients have 
had prednisone discontinued and all receive smaller 
maintenance doses of azathioprine. 
Four additional patients had died. The patient 
in case 4 succumbed 118 days after surgery of an 
unrecognized paravertebral gutter abscess. The pa- 
tient in case 7 died of a perinephric abscess sur- 
rounding the homograft 79 days after transplanta- 
tion. The patient in case 8 died unexpectedly 62 
days after transplantation of an unexplained cen- 
tral nervous system disorder, characterized by the 
acute onset of coma and convulsions with death 
24 hours later. The patient in case 9 died six 
months and 24 days after transplantation as a con- 
sequence of a massive gastrointestinal hemorrhage 
from a duodenal ulcer which was unsuccessfully 
treated with vagotomy, suture transfixion of the 
ulcer, and pyeloroplasty. The last patient was still 
on maintenance doses of prednisone. In all but the 
last case, renal function was essentially unimpaired 
prior to death. 
Since submission of this report, use of thymec- 
tomy has been discontinued because of excessive 
morbidity encountered. Splenectomy is still em- 
ployed. When it is necessary to use donors and 
recipients of different ABO blood groups, incom- 
patibilities are accepted only when they confirm 
to that scheme already defined for the use of mis- 
matched blood, transfusions in which 0 is a uni- 
versal donor and AB the universal recipient. Thus 
0 to A, 0 to B, and so forth would still be used, as 
well as A to AB and B to AB. Transfers such as 
A to 0 ,  B to 0, and B to A would no longer be 
considered. 
4200 E 9th Ave, Denver ( Dr. Starzl). 
Drs. Gilbert Hermann, Oliver Stonington, Martin Hutt, 
David Rifkind, David Talrnage, I.C.S. Knight, Mathew 
Block, and Robert Virtue aided in this study. 
The azathioprine used in this study was provided as 
Imuran (577-322) by Dr. Donald S. Searle of Burroughs- 
Wellcome Co., Tuckahoe, NY. Actinomycin C was pro- 
vided as Sanamycin by Dr. Donald Whitfield of FBA Phar- 
maceuticals, Haywards Heath, Sussex, England. 
References 
1. Starzl, T.E., et al: Renal Transplantation in Identical 
Twins, Arch Surg (Chicago) 86:600,1963 
2. Goodwin, W.E., and Martin, D.C.: Transplantation of 
Kidney, Read before the American Urological Association, 
St. Louis, May'l5, 1963, J Urol, to be published. 
3. Hume, D.M., et al: Renal Homotransplantation in Man 
in Modified Recipients, Read before the American Surgical 
Association, Phoenix, Ariz, April 5, 1963, Ann Surg 158:608, 
1963. 
4. Starzl, T.E., et al: Renal Homografts in Patients with 
Major Donor-Recipient Blood Group Incompatibilities, 
Surgery, to be published. 
5.  Marchioro, T.L.; Waddell, W.R.; and Starzl, T.E.: 
Use of Extracorporeal Cadaver Perfusion for Preparation of 
Organ Homografts, Surg Forum 14:174, 1963. 
6. Murray, J.E., and Harrison, J.H.: Surgical Manage- 
ment of 50 Patients With Kidney Transplants Including 
18 Pairs of Twins, Amer J Surg 105:205, 1963. 
7 .  Calne, R.Y., and Murray, J.E.: Inhibition of Rejection 
of Renal Homografts in Dogs by Burroughs Wellcome 
57-322, Surg Forum 12:118, 1961. 
8. Murray, J.E., et al: Kidney Transplantation in Modi- 
fied Recipients, Ann Surg 156:337, 1962. 
9 .  Goodwin, W.E., et al: Human Renal Transplantation: 
I. Clinical Experiences With Six Cases of Renal Homotrans- 
plantation, J Urol89:13, 1963. 
10. Hektoen, L.: Further Observations on Effects of 
Roentgenization and Splenedomy on Antibody Formation, 
J lnfect Dis 27:23, 1920. 
11. Rowley, D.A.: Formation of Circulating Antibodies 
in Splenectomized Human Being Following Intravenous 
Injection of Heterologous Erythrocytes, J Immun 65:515, 
1950. 
12. Gunderson, C.H., et al: Tissue and Cellular Changes 
Associated With Antibody Formation in Rat Spleen, JAMA 
180:1038, 1962. 
13. Harris, T.N.; Rhodes, J.; and Stokes, J.: Study of 
Thymus and Spleen in Formation of Antibody in Rabbit, 
J Immun 58:27, 1948. 
14. Miller, J.F.A.P.: Immunologic Significance of Thymus 
of Adult Mouse, Nature (London) 195:1318, 1962. 
15. Miller, J.F.A.P.: Immunity and Thymus, Lancet 2:43, 
1963. 
Printed in U.S.A. 
